<DOC>
	<DOCNO>NCT02862028</DOCNO>
	<brief_summary>Objectives : To evaluate safety effectiveness cell therapy use herinCAR-PD1 cell treat relapse refractory cancer . Eligibility : Individuals great equal 18 year age less equal 70 year age diagnose relapsed refractory cancer respond relapsed standard treatment .</brief_summary>
	<brief_title>PD-1 Antibody Expressing CAR-T Cells EGFR Family Member Positive Advanced Solid Tumor ( Lung , Liver Stomach )</brief_title>
	<detailed_description>A total 20 patient may enrol period 1-2 year .</detailed_description>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>1 . Age 18~65 year old , male female ; 2 . Life expectancy≥6 month ; 3 . ECOG score : 03 ; 4 . Advanced solid tumor ( lung cancer , gastric cancer , liver cancer ) diagnose pathological clinical physician ; 5 . Enough venous channel , contraindication separation collection white blood cell ; 6 . Immunohistochemistry RTPCR technology use determine positive EGFR family ( include EGFR , HER2 , HER4 ) IGFR1 protein . At least one protein express immunohistochemical tumor tissue less grade 2 2+ score . The level protein define follow : ( accord cell stain ) : grade 0 : without stain ; grade 1 : 125 % ; grade 2 : 2650 % grade 3 : 51100 % ; ( According intensity ) : negative ; 1+ ; 2+ 3+ ; 7 . Laboratory examination : white blood cell≥3 x 10*9/L , blood platelet count≥60 x 10*/L , hemoglobin≥85g/L ; lymphocyte count≥15 % , total bilirubin≤100 mol/L ; ALT AST less five time normal level ; serum creatinine less 1.5 time normal level； 8 . Signed inform consent； 9 . Women childbearing age must evidence negative pregnancy test willing practice birth control 2 week follow cell transfusion . 1 . Expected Overall survival ＜ 6 month ; 2 . Patients uncontrolled hypertension , unstable coronary disease ( uncontrolled arrhythmia , unstable angina , decompensated congestive heart failure ( &gt; Class II , NYHA ) , myocardial infarction within 6 month . 3 . Abnormal lung function : FEV ( forced expiratory volume ) &lt; 30 % prediction , DLCO ( diffuse capacity lung carbon monoxide ) &lt; 30 % prediction , blood oxygen saturation &lt; 90 % ; 4 . Other serious disease : nervous , mental disorder , immune regulatory disease , metabolic disease , infectious disease , etc ; 5 . Unable unwilling provide inform consent , fail comply test requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>PD-1 antibody</keyword>
	<keyword>CAR-T cell</keyword>
	<keyword>EGFR family</keyword>
	<keyword>advanced solid tumor</keyword>
</DOC>